WARSAW, Ind., Jan. 12 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. , an independent provider of products to the global orthopedic device industry, today announced it will release fourth quarter and full year financial results for the period ended December 31, 2005 after the market closes on Wednesday, February 15, 2006. Symmetry Medical will host an accompanying conference call at 8:00 a.m. EST on Thursday, February 16, 2006.
A live Web cast of the conference call will be available online from the investor relations page of the Company’s corporate Web site at http://www.symmetrymedical.com. The dial-in numbers are (866) 362-5158 for domestic callers and (617) 597-5397 for international callers. The reservation number for both is 95273302. After the live Web cast, the call will remain available on Symmetry’s Web site through March 16, 2006. In addition, a telephonic replay of the call will be available until March 2, 2006. The replay dial-in numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Please use reservation code 37839930.
About Symmetry Medical Inc.
Symmetry Medical Inc. is an independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including dental, osteobiologic and endoscopy sectors and provides limited specialized products and services to non- healthcare markets, such as the aerospace market.
Forward Looking Statements.
Statements in this press release regarding Symmetry Medical Inc.'s business, which are not historical facts may be “forward-looking statements” that involve risks and uncertainties. Forward-looking statements frequently are identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend” and similar words indicating possible future events or actions. Such predictive statements are not guarantees of future performance, and actual results could differ materially from our current expectations. Certain factors that could cause actual results to differ include: the loss of one or more customers; the development of new products or product innovations by our competitors; product liability; changes in management; changes in conditions affecting the economy, orthopedic device manufacturers or the medical device industry generally; and changes in government regulation of medical devices and third-party reimbursement practices. For a discussion of these and other risks and uncertainties that could cause actual results to differ from those contained in the forward- looking statements, we refer you to the Company’s July 15, 2005 registration statement filed on Form S-1 which contains a detailed explanation of the many risk factors as well as the Company’s other filings with the Securities and Exchange Commission which are available on the SEC’s website at http://www.sec.gov. All forward-looking statements are qualified in their entirety by this cautionary statement, and Symmetry Medical Inc. undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.
Contacts: Investors/Media: The Ruth Group Stephanie Carrington/Jason Rando 646-536-7017/7025 scarrington@theruthgroup.comjrando@theruthgroup.com Symmetry Medical Inc. Andrew Miclot Senior Vice President Marketing, Sales & Business Development Investor Relations Officer 574-269-7390 ext. 1002
Symmetry Medical Inc.
CONTACT: Investors or Media: Stephanie Carrington, +1-646-536-7017,scarrington@theruthgroup.com, or Jason Rando, +1-646-536-7025,jrando@theruthgroup.com, both of The Ruth Group, for Symmetry Medical Inc.;or Andrew Miclot, Senior Vice President, Marketing, Sales & BusinessDevelopment Investor Relations Officer, of Symmetry Medical Inc.,+1-574-269-7390, ext. 1002
Web site: http://www.symmetrymedical.com/
